Detection of bone marrow‐disseminated breast cancer cells using an RT‐PCR assay of MUC5B mRNA
Open Access
- 22 November 2002
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 103 (4) , 550-555
Abstract
The evaluation of disseminated epithelial tumor cells in breast cancer patients has generated considerable interest due to its potential association with disease recurrence. Our work was performed to analyze the usefulness of 5 mucin genes expression (MUC2, MUC3, MUC5B, MUC6 and MUC7), using RT‐PCR assays, to detect disseminated cancer cells in patients with operable breast cancer. The highest frequencies of positive RT‐PCR tests in breast tumor extracts were observed for MUC5B (7/15) and MUC7 (5/12). The best specificity, negative results on all peripheral blood mononuclear (PBMN) cell samples from healthy donors, were shown for MUC2, MUC5B and MUC6 RT‐PCR assays. Thus, we selected MUC5B as a target gene for further evaluation. Using a nested RT‐PCR, MUC5B mRNA transcripts were detected in 16/31 primary breast tumors (but not in 36 samples of normal PBMN cells) and in the human MCF‐7 breast cancer cell line but not in BT20, MDA, T47D and ZR‐75 breast cancer cell lines, indicating that MUC5B mRNA is expressed in a population of breast cancer cells. Using this method, 9/46 patients (19.5%) who underwent curative surgery showed positive MUC5B mRNA in bone marrow aspirates obtained prior to surgery, including 5/24 patients (20.8%) with stage I or II breast cancer, without histopathologic lymph node involvement. These results indicate that MUC5B mRNA could be a specific marker applicable to the molecular diagnosis of breast cancer cell dissemination. A comparative evaluation between MUC5B mRNA, cytokeratin 19 (CK19) mRNA and carcinoembryonic antigen (CEA) mRNA in all bone marrow aspirates suggests a putative complementation for molecular detection of disseminated carcinoma cells. Considering that breast cancer is characterized by a great phenotypic heterogeneity, the use of multimarker approach could contribute to tumor cell detection in bone marrow and blood.Keywords
Funding Information
- Comisión Honoraria de Lucha Contra el Cáncer (Uruguay)
- Manuel Pérez Foundation (Uruguay)
- ECOS France-Uruguay Program
This publication has 36 references indexed in Scilit:
- Bone marrow staging for breast cancer: Is it better than axillary node dissection?Seminars in Oncology, 2001
- The Amount of MUC5B Mucin in Cervical Mucus Peaks at MidcycleThe Journal of Clinical Endocrinology & Metabolism, 2001
- Cytokeratin-Positive Cells in the Bone Marrow and Survival of Patients with Stage I, II, or III Breast CancerNew England Journal of Medicine, 2000
- Classification of isolated tumor cells and micrometastasisCancer, 1999
- The Amino-Terminal Sequence of MUC5B Contains Conserved Multifunctional D Domains: Implications for Tissue-Specific Mucin FunctionsBiochemical and Biophysical Research Communications, 1998
- Human Mucin Genes MUC2, MUC3,MUC4, MUC5AC, MUC5B, andMUC6 Express Stable and Extremely Large mRNAs and Exhibit a Variable Length PolymorphismJournal of Biological Chemistry, 1998
- Human Mucin Genes Assigned to 11p15.5: Identification and Organization of a Cluster of GenesGenomics, 1996
- Epithelial Mucin GenesAnnual Review of Physiology, 1995
- Expression of human mucin genes in respiratory, digestive, and reproductive tracts ascertained by in situ hybridization.Journal of Histochemistry & Cytochemistry, 1993
- Monoclonal antibodies in the detection and therapy of micrometastatic epithelial cancersCurrent Opinion in Immunology, 1992